Figure 5
Male BRAFfl/fl/Cre+/− mice were treated with corn-oil (CO) or tamoxifen in CO (Tx) 4 days before minipumps were implanted to deliver PBS or 40 mg/kg/d phenylephrine in PBS (PE) for 7 d. (A) Representative M-mode echocardiograms taken from short axis views of the heart (upper panels) with analysis of echocardiograms to assess cardiac dimensions (lower panels). Abbreviations: LVID, left ventricle internal diameter; WT, left ventricle wall thickness (posterior plus anterior walls). Diastolic measurements are shown. (B) mRNA expression in mouse hearts after 7 d treatment with phenylephrine. (C) Haematoxylin and eosin staining of mouse heart sections (left panels) with assessment of cardiomyocyte cross-sectional area (CSA; right panel). Images and measurements are from the periphery of the left ventricle. (D,E) Picrosirius red staining of mouse heart sections showing short axis views of the whole heart (D) with enlarged sections (E) from the same views (the red stain shows accumulation of fibrotic material). Representative (average) images are shown for mice treated with CO/PBS (i), Tx/PBS (ii), CO/PE (iii) and Tx/PE (v). Additional images are shown for the most severe degree of fibrosis with CO/PE (iv) and Tx/PE (vi). (F) Quantification of fibrosis. This was scored as: 1 = the least amount of fibrosis; 2 = low level fibrosis; 3 = high level fibrosis in at least one area of the myocardium; 4 = high level fibrosis throughout the myocardium (half scores were used). Data are presented as individual values with means ± SEM. Statistical analysis used two-way (A,C,F) or one-way (B) ANOVA with Holm-Sidak’s post-test. Statistically significant values (P<0.05) are in bold type.
Cardiomyocyte BRAF knockout does not inhibit cardiomyocyte hypertrophy induced by phenylephrine in male mouse hearts but increases cardiac fibrosis

Male BRAFfl/fl/Cre+/− mice were treated with corn-oil (CO) or tamoxifen in CO (Tx) 4 days before minipumps were implanted to deliver PBS or 40 mg/kg/d phenylephrine in PBS (PE) for 7 d. (A) Representative M-mode echocardiograms taken from short axis views of the heart (upper panels) with analysis of echocardiograms to assess cardiac dimensions (lower panels). Abbreviations: LVID, left ventricle internal diameter; WT, left ventricle wall thickness (posterior plus anterior walls). Diastolic measurements are shown. (B) mRNA expression in mouse hearts after 7 d treatment with phenylephrine. (C) Haematoxylin and eosin staining of mouse heart sections (left panels) with assessment of cardiomyocyte cross-sectional area (CSA; right panel). Images and measurements are from the periphery of the left ventricle. (D,E) Picrosirius red staining of mouse heart sections showing short axis views of the whole heart (D) with enlarged sections (E) from the same views (the red stain shows accumulation of fibrotic material). Representative (average) images are shown for mice treated with CO/PBS (i), Tx/PBS (ii), CO/PE (iii) and Tx/PE (v). Additional images are shown for the most severe degree of fibrosis with CO/PE (iv) and Tx/PE (vi). (F) Quantification of fibrosis. This was scored as: 1 = the least amount of fibrosis; 2 = low level fibrosis; 3 = high level fibrosis in at least one area of the myocardium; 4 = high level fibrosis throughout the myocardium (half scores were used). Data are presented as individual values with means ± SEM. Statistical analysis used two-way (A,C,F) or one-way (B) ANOVA with Holm-Sidak’s post-test. Statistically significant values (P<0.05) are in bold type.

Close Modal

or Create an Account

Close Modal
Close Modal